The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder

BACKGROUND: Augmentation with second-generation antipsychotics (SGAs) represents an evidence-based psychopharmacotherapeutic strategy recommended in case of insufficient response to the first-line antidepressant (AD) treatment in major depressive disorder (MDD). Comparative evidence regarding effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartova, Lucie, Fugger, Gernot, Dold, Markus, Kautzky, Alexander, Swoboda, Marleen Margret Mignon, Rujescu, Dan, Zohar, Joseph, Souery, Daniel, Mendlewicz, Julien, Montgomery, Stuart, Fabbri, Chiara, Serretti, Alessandro, Kasper, Siegfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832223/
https://www.ncbi.nlm.nih.gov/pubmed/34637516
http://dx.doi.org/10.1093/ijnp/pyab066

Ejemplares similares

Ejemplares similares